Complete response to trastuzumab and chemotherapy in recurrent urothelial bladder carcinoma with HER2 gene amplification: A case report

doi:10.12998/wjcc.v8.i3.594

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6042)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

277

WORD

173

HTML

3253

Figures (1-2)

308

Tables (1-3)

346

Sum=4357

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

748

Download

938

Sum=1686

Feb 6, 2020 (publication date) through Feb 3, 2025

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Feb 6, 2020; 8(3): 594-599
Published online Feb 6, 2020. doi: 10.12998/wjcc.v8.i3.594

Table 3 Selected trials of anti-HER2 agents in advanced bladder cancer

Regimen	Phase	No of patients	Prior chemotherapy	Target enrichment	OR (%)	mOS (mo)
Carboplatin/ paclitaxel/ gemcitabine/trastuzmab	I/II	57	No	Yes	70	14.1
Lapatinib	II	59	Yes	No	1.7	4.5
Lapatinib maintenance after first-line chemotherapy	II/III	116	No	Yes	14	12.6

OR: Overall response; mOS: Median overall survival.

Citation: Jiang Q, Xie MX, Zhang XC. Complete response to trastuzumab and chemotherapy in recurrent urothelial bladder carcinoma with HER2 gene amplification: A case report. World J Clin Cases 2020; 8(3): 594-599
URL: https://www.wjgnet.com/2307-8960/full/v8/i3/594.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i3.594